ENDRA Life Sciences NDRA Holds Steady Near Support as MicroCap Biotech Awaits Catalysts OZKAP Q1 2026 Earnings Preferred Stock Reports Small EPS Miss Stock Declines SNPS Q1 2026 Earnings EPS Beats Estimates by 414 Amid Mixed Market Response ICG Q4 2025 Earnings WiderthanExpected Loss Sends Shares Lower NMM Q1 2026 Earnings Strong EPS Beat of 1711 Despite Modest Stock Pullback MBRX Q1 2026 Earnings EPS Misses Estimates Amid Continued PreRevenue Phase FULC Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Discipline CRBD Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Steady Operations